Literature DB >> 4206029

Immunological study of the heat-labile enterotoxins of Escherichia coli and Vibrio cholerae.

C L Gyles.   

Abstract

Immunodiffusion experiments were conducted to associate a precipitin line with Escherichia coli heat-labile enterotoxin (LT). Wild strains of porcine and of human enteropathogenic E. coli as well as laboratory-derived enterotoxigenic variants of E. coli K-12 were used for LT antigen preparations. These were produced mainly by ultrafiltration and ammonium sulfate precipitation of broth culture supernatants. When antisera with anti-LT activity were reacted with antigen preparations from Ent(+) and Ent(-) variants of E. coli K-12, a line "a" was given by Ent(+) but not by Ent(-) preparations. Line "a" was removed by absorption of anti-LT serum with antigen preparation from an Ent(+)E. coli K-12, but was unaffected when the antigen preparation used to absorb the serum was from an Ent(-)E. coli K-12. A line identical to "a" was given by antigen preparations from wild strains of porcine enteropathogenic E. coli reacted with homologous or heterologous anti-LT sera. One human strain of enteropathogenic E. coli was shown to possess an antigen identical to that which gave rise to line "a." To demonstrate this line it was necessary to use high concentrations of gammaglobulin and high concentrations of the crude antigen preparations. LT preparations reacted with anticholera toxin to give a line "c," which showed a reaction of partial identity with line "b" produced by reaction of pure choleragenoid and anticholera toxin. Lines "a" and "c" gave reactions of identity.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4206029      PMCID: PMC414845          DOI: 10.1128/iai.9.3.564-570.1974

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  Plasmid-associated enterotoxin production in a strain of Escherichia coli isolated from humans.

Authors:  F J Skerman; S B Formal; S Falkow
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

2.  Preliminary characterization of the heat-labile enterotoxin of Escherichia coli F11(P155).

Authors:  S Lariviére; C L Gyles; D A Barnum
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

3.  The relationship between two apparently different enterotoxins produced by enteropathogenic strains of Escherichia coli of porcine origin.

Authors:  H W Smith; C L Gyles
Journal:  J Med Microbiol       Date:  1970-08       Impact factor: 2.472

4.  Studies on Escherichia coli enterotoxin.

Authors:  H W Smith; S Halls
Journal:  J Pathol Bacteriol       Date:  1967-04

5.  Pathogenesis of experimental cholera: biologic ativities of purified procholeragen A.

Authors:  R A Finkelstein; P Atthasampunna; M Chulasamaya; P Charunmethee
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

6.  A heat-labile enterotoxin from strains of Eschericha coli enteropathogenic for pigs.

Authors:  C L Gyles; D A Barnum
Journal:  J Infect Dis       Date:  1969-10       Impact factor: 5.226

7.  Fatalities due to malaria in the United States, 1966-1969.

Authors:  A S Dover; K A Western
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

8.  Chemical and physical properties of cholera exo-enterotoxin (choleragen) and its spontaneously formed toxoid (choleragenoid).

Authors:  J J Lospalluto; R A Finkelstein
Journal:  Biochim Biophys Acta       Date:  1972-01-26

9.  The transmissible nature of enterotoxin production in a human enteropathogenic strain of Escherichia coli.

Authors:  H W Smith; M A Linggood
Journal:  J Med Microbiol       Date:  1971-08       Impact factor: 2.472

10.  Monospecific equine antiserum against cholera exo-enterotoxin.

Authors:  R A Finkelstein
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

  10 in total
  32 in total

1.  Activation of adenylate cyclase by heat-labile Escherichia coli enterotoxin. Evidence for ADP-ribosyltransferase activity similar to that of choleragen.

Authors:  J Moss; S H Richardson
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

2.  The effect of attapulgite and charcoal on enterotoxicity of Vibrio cholerae and Escherichia coli enterotoxins in rabbits.

Authors:  M M Drucker; J Goldhar; P L Ogra; E Neter
Journal:  Infection       Date:  1977       Impact factor: 3.553

3.  Isolation of a novel transposon which carries the Escherichia coli enterotoxin STII gene.

Authors:  C H Lee; S T Hu; P J Swiatek; S L Moseley; S D Allen; M So
Journal:  J Bacteriol       Date:  1985-05       Impact factor: 3.490

4.  Immunological cross-reactivity between a heat-labile enterotoxin(s) of Escherichia coli and subunits of Vibrio cholerae enterotoxin.

Authors:  J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

5.  Immunological cross-reactivity of enterotoxins of Aeromonas hydrophila and cholera toxin.

Authors:  C James; M Dibley; V Burke; J Robinson; M Gracey
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

6.  Protective effect of active immunization with purified Escherichia coli heat-labile enterotoxin in rats.

Authors:  F A Klipstein; R F Engert
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

7.  The effect of adsorbant and anti-inflammatory drugs on secretion in ligated segments of pig intestine infected with Escherichia coli.

Authors:  C L Gyles; M Zigler
Journal:  Can J Comp Med       Date:  1978-07

8.  Assay of Escherichia coli enterotoxins by in vivo perfusion in the rat jejunum.

Authors:  F A Klipstein; C S Lee; R F Engert
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

9.  Direct serological assay for the heat-labile enterotoxin of Escherichia coli, using passive immune hemolysis.

Authors:  D J Evans; D G Evans
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

10.  Evidence that a non-O1 Vibrio cholerae produces enterotoxin that is similar but not identical to cholera enterotoxin.

Authors:  K Yamamoto; Y Takeda; T Miwatani; J P Craig
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.